Literature DB >> 1446056

Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

D E Haagensen1, P Stewart, W G Dilley, S A Wells.   

Abstract

The effect of steroid hormones on modulating the secretion rates of three human breast gross cystic disease fluid proteins (GCDFP-15, GCDFP-24, and GCDFP-44) by T47D breast carcinoma cells in tissue culture was evaluated. Androgens (dihydrotestosterone or fluoxymesterone) were capable of stimulating the secretion rates for all three GCDFP's while showing a minimal trend toward slowing the growth rate of T47D cells. This is the first study which shows that androgens can specifically stimulate all three of the major breast GCDFP's concomitantly. Progesterone, and three synthetic progestins, all showed inhibition of the growth rate of T47D cells while causing enhancement of the secretion of GCDFP-15 and GCDFP-44, and only minimal effect on the secretion rate of GCDFP-24. Estradiol was essentially neutral to the growth rate of the T47D cells in our test system. Estradiol did cause a mild enhancement of GCDFP-44 secretion rate, with no appreciable effect on GCDFP-15 or GCDFP-24 secretion rates. These findings suggest that an androgenic stimulus may be involved in the secretion of GCDFP's associated with breast gross cystic disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446056     DOI: 10.1007/bf01831479

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  50 in total

1.  Further characterization of the light breast cyst fluid protein, GCDFP-15.

Authors:  B Vandewalle; L Hornez; P Vennin; J P Peyrat; J Lefebvre
Journal:  Biochimie       Date:  1986-05       Impact factor: 4.079

2.  Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.

Authors:  P C England; R A Sellwood; R E Knyba; J D Irvine
Journal:  Clin Oncol       Date:  1981-09

3.  Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.

Authors:  G Mazoujian
Journal:  Am J Dermatopathol       Date:  1990-10       Impact factor: 1.533

4.  Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.

Authors:  M Balbín; J M Freije; A Fueyo; L M Sánchez; C López-Otín
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.

Authors:  J Simard; S Dauvois; D E Haagensen; C Lévesque; Y Mérand; F Labrie
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

6.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts.

Authors:  S R Wellings; C E Alpers
Journal:  Hum Pathol       Date:  1987-04       Impact factor: 3.466

8.  Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.

Authors:  K B Horwitz; G R Freidenberg
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

9.  Steroid receptor analyses of nine human breast cancer cell lines.

Authors:  K B Horwitz; D T Zava; A K Thilagar; E M Jensen; W L McGuire
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

10.  Androgen conjugates in human breast cyst fluids.

Authors:  W R Miller; M M Roberts; R J Creel; P L Yap; R W Kelly; A P Forrest
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

View more
  7 in total

1.  A strong association between body fat mass and protein profiles in nipple aspirate fluid of healthy premenopausal non-lactating women.

Authors:  Yafei Huang; Manubai Nagamani; Karl E Anderson; Alexander Kurosky; Anthony M Haag; James J Grady; Lee-Jane W Lu
Journal:  Breast Cancer Res Treat       Date:  2006-09-27       Impact factor: 4.872

2.  Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis.

Authors:  Hui Chen; Yingli Li; Jie Du; Yan Cao; Xiaoli Li
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

3.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

5.  Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner.

Authors:  Sanjeev K Baniwal; Nyam-Osor Chimge; V Craig Jordan; Debu Tripathy; Baruch Frenkel
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

6.  Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.

Authors:  R E Hall; J O Aspinall; D J Horsfall; S N Birrell; J M Bentel; R L Sutherland; W D Tilley
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

7.  Genetic background influences murine prostate gene expression: implications for cancer phenotypes.

Authors:  Daniella Bianchi-Frias; Colin Pritchard; Brigham H Mecham; Ilsa M Coleman; Peter S Nelson
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.